Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9716, pp. 727 - 734
Summary Background Remote ischaemic preconditioning attenuates cardiac injury at elective surgery and angioplasty. We tested the hypothesis that remote...
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | PRECONDITIONING PROTECTS | THROMBUS ASPIRATION | SIZE | THROMBECTOMY | INJURY | REPERFUSION | ARTERY | DEPENDENT MECHANISM | Angioplasty, Balloon, Laser-Assisted | Prospective Studies | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Myocardial Infarction - therapy | Troponin T - blood | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Ticlopidine - administration & dosage | Female | Technetium Tc 99m Sestamibi | Drug Therapy, Combination | Radiopharmaceuticals | Echocardiography | Myocardium - pathology | Treatment Outcome | Hospitalization | Ticlopidine - analogs & derivatives | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Arm - blood supply | Ischemic Preconditioning, Myocardial - methods | Myocardial Reperfusion Injury - prevention & control | Care and treatment | Research | Angioplasty | Health aspects | Heart attack | Heart failure | Emergency medical care | Heart attacks | Biomedical research | Statistical analysis | Cardiology
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | PRECONDITIONING PROTECTS | THROMBUS ASPIRATION | SIZE | THROMBECTOMY | INJURY | REPERFUSION | ARTERY | DEPENDENT MECHANISM | Angioplasty, Balloon, Laser-Assisted | Prospective Studies | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Myocardial Infarction - therapy | Troponin T - blood | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Ticlopidine - administration & dosage | Female | Technetium Tc 99m Sestamibi | Drug Therapy, Combination | Radiopharmaceuticals | Echocardiography | Myocardium - pathology | Treatment Outcome | Hospitalization | Ticlopidine - analogs & derivatives | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Arm - blood supply | Ischemic Preconditioning, Myocardial - methods | Myocardial Reperfusion Injury - prevention & control | Care and treatment | Research | Angioplasty | Health aspects | Heart attack | Heart failure | Emergency medical care | Heart attacks | Biomedical research | Statistical analysis | Cardiology
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 10, pp. 1343 - 1345
Cardiovascular | coronary bifurcation | percutaneous coronary intervention | coronary stent(s) | left main coronary artery | coronary revascularization | percutaneous coronary intervention | left main coronary artery | coronary revascularization | CARDIAC & CARDIOVASCULAR SYSTEMS | BIFURCATION LESIONS | FOLLOW-UP | INTERVENTION | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Humans | Female | Male | Stents
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9667, pp. 897 - 910
Summary Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical...
Internal Medicine | TRIAL | TOMOGRAPHY | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | INTRACORONARY ULTRASOUND | ANGIOPLASTY | 3-DIMENSIONAL INTRAVASCULAR ULTRASOUND | IMPLANTATION | ARTERY LESIONS | ATHEROSCLEROTIC PLAQUE COMPOSITION | LUMEN | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Clinical Trials as Topic | Absorbable Implants | Drug-Eluting Stents - adverse effects | Multicenter Studies as Topic | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Everolimus | Coronary Restenosis - etiology | Usage | Patient outcomes | Endovascular stents | Studies | Heart attacks | Medical imaging | Stents | Coronary vessels
Internal Medicine | TRIAL | TOMOGRAPHY | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | INTRACORONARY ULTRASOUND | ANGIOPLASTY | 3-DIMENSIONAL INTRAVASCULAR ULTRASOUND | IMPLANTATION | ARTERY LESIONS | ATHEROSCLEROTIC PLAQUE COMPOSITION | LUMEN | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Clinical Trials as Topic | Absorbable Implants | Drug-Eluting Stents - adverse effects | Multicenter Studies as Topic | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Everolimus | Coronary Restenosis - etiology | Usage | Patient outcomes | Endovascular stents | Studies | Heart attacks | Medical imaging | Stents | Coronary vessels
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9720, pp. 1090 - 1099
Summary Background In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing the risk of stent...
Internal Medicine | DRUG | MEDICINE, GENERAL & INTERNAL | THROMBOSIS | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | ARTERY LESIONS | DISEASE | ACUTE MYOCARDIAL-INFARCTION | FOLLOW-UP | ENDEAVOR | OUTCOMES | Single-Blind Method | Sirolimus - analogs & derivatives | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Retreatment | Thrombosis - etiology | Coronary Disease - therapy | Female | Aged | Myocardial Infarction - etiology | Sirolimus - adverse effects | Care and treatment | Patient outcomes | Dosage and administration | Coronary heart disease | Health aspects | Immunosuppressive agents | Stent (Surgery) | Studies | Intervention | Heart attacks | Medical imaging | Angioplasty | Cardiovascular disease | Clinical medicine | Acute coronary syndromes | Stents | Blood clots
Internal Medicine | DRUG | MEDICINE, GENERAL & INTERNAL | THROMBOSIS | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | ARTERY LESIONS | DISEASE | ACUTE MYOCARDIAL-INFARCTION | FOLLOW-UP | ENDEAVOR | OUTCOMES | Single-Blind Method | Sirolimus - analogs & derivatives | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Retreatment | Thrombosis - etiology | Coronary Disease - therapy | Female | Aged | Myocardial Infarction - etiology | Sirolimus - adverse effects | Care and treatment | Patient outcomes | Dosage and administration | Coronary heart disease | Health aspects | Immunosuppressive agents | Stent (Surgery) | Studies | Intervention | Heart attacks | Medical imaging | Angioplasty | Cardiovascular disease | Clinical medicine | Acute coronary syndromes | Stents | Blood clots
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9616, pp. 899 - 907
Summary Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once the acute recoil and...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | 6-MONTH | THROMBOSIS | COVERAGE | POLYMER | 1ST HUMAN-EXPERIENCE | FOLLOW-UP | INTRAVASCULAR ULTRASOUND | II TRIAL | INSIGHTS | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Prospective Studies | Humans | Middle Aged | Coronary Restenosis | Male | Absorbable Implants | Angioplasty, Balloon, Coronary | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Safety | Everolimus | Clinical trials | Heart attacks | Angioplasty | Stents | Coronary vessels
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | 6-MONTH | THROMBOSIS | COVERAGE | POLYMER | 1ST HUMAN-EXPERIENCE | FOLLOW-UP | INTRAVASCULAR ULTRASOUND | II TRIAL | INSIGHTS | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Prospective Studies | Humans | Middle Aged | Coronary Restenosis | Male | Absorbable Implants | Angioplasty, Balloon, Coronary | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Safety | Everolimus | Clinical trials | Heart attacks | Angioplasty | Stents | Coronary vessels
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 10, pp. 999 - 1009
Objectives This study sought to demonstrate the 5-year clinical and functional multislice computed tomography angiographic results after implantation of the...
Cardiovascular | everolimus | bioresorbable scaffold | noninvasive functional assessment | multislice computed tomography | FRACTIONAL FLOW RESERVE | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROSCLEROTIC PLAQUES | CT ANGIOGRAPHY | BLOOD-FLOW | DIAGNOSTIC-ACCURACY | STENT RECOIL | SHEAR-STRESS | ABSORB TRIAL | INTRAVASCULAR ULTRASOUND | DISCOVER-FLOW
Cardiovascular | everolimus | bioresorbable scaffold | noninvasive functional assessment | multislice computed tomography | FRACTIONAL FLOW RESERVE | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROSCLEROTIC PLAQUES | CT ANGIOGRAPHY | BLOOD-FLOW | DIAGNOSTIC-ACCURACY | STENT RECOIL | SHEAR-STRESS | ABSORB TRIAL | INTRAVASCULAR ULTRASOUND | DISCOVER-FLOW
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9934, pp. 2047 - 2056
Summary Background In head-to-head comparisons of coronary drug-eluting stents, the primary endpoint is traditionally assessed after 9–12 months. However, the...
Internal Medicine | ANGIOGRAPHIC OUTCOMES | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | SCANDINAVIAN ORGANIZATION | SAFETY | BARE-METAL STENTS | NON-INFERIORITY TRIAL | FOLLOW-UP | INTERVENTION | ENDEAVOR-III | ARTERY-DISEASE | Single-Blind Method | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Cytostatic Agents - administration & dosage | Male | Treatment Outcome | Cytostatic Agents - therapeutic use | Drug-Eluting Stents - adverse effects | Cytostatic Agents - adverse effects | Sirolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Coronary Thrombosis - etiology | Myocardial Infarction - etiology | Research Design | Sirolimus - adverse effects | Complications and side effects | Usage | Drug-eluting stents | Zotarolimus | Dosage and administration | Research | Health aspects | Comparative analysis | Stent (Surgery) | Transluminal angioplasty | Heart | Cardiology | Studies | Heart attacks | Angina pectoris | Stents | Coronary vessels | Clinical outcomes
Internal Medicine | ANGIOGRAPHIC OUTCOMES | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | SCANDINAVIAN ORGANIZATION | SAFETY | BARE-METAL STENTS | NON-INFERIORITY TRIAL | FOLLOW-UP | INTERVENTION | ENDEAVOR-III | ARTERY-DISEASE | Single-Blind Method | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Cytostatic Agents - administration & dosage | Male | Treatment Outcome | Cytostatic Agents - therapeutic use | Drug-Eluting Stents - adverse effects | Cytostatic Agents - adverse effects | Sirolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Coronary Thrombosis - etiology | Myocardial Infarction - etiology | Research Design | Sirolimus - adverse effects | Complications and side effects | Usage | Drug-eluting stents | Zotarolimus | Dosage and administration | Research | Health aspects | Comparative analysis | Stent (Surgery) | Transluminal angioplasty | Heart | Cardiology | Studies | Heart attacks | Angina pectoris | Stents | Coronary vessels | Clinical outcomes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 5, pp. 463 - 470
Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions Lisette Okkels Jensen, Michael Mæng, Anne...
Cardiovascular | Internal Medicine | UNCOATED STENTS | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | SAFETY | POOLED ANALYSIS | COHORT | OUTCOMES | CLINICAL-PRACTICE | ARTERY-DISEASE | Stents - statistics & numerical data | Myocardial Infarction - epidemiology | Drug Delivery Systems - statistics & numerical data | Prospective Studies | Coronary Thrombosis - epidemiology | Follow-Up Studies | Risk Assessment | Comorbidity | Humans | Middle Aged | Male | Cause of Death | Incidence | Outcome and Process Assessment (Health Care) | Denmark - epidemiology | Female | Registries | Aged | Causality | Stents - adverse effects | Drug Delivery Systems - adverse effects | Heart diseases | Thrombosis | Stent (Surgery) | Blood clot | Mortality | Drug therapy | Cardiology | Epidemiology | Heart attacks | Hospitals | Stents | Coronary vessels
Cardiovascular | Internal Medicine | UNCOATED STENTS | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | SAFETY | POOLED ANALYSIS | COHORT | OUTCOMES | CLINICAL-PRACTICE | ARTERY-DISEASE | Stents - statistics & numerical data | Myocardial Infarction - epidemiology | Drug Delivery Systems - statistics & numerical data | Prospective Studies | Coronary Thrombosis - epidemiology | Follow-Up Studies | Risk Assessment | Comorbidity | Humans | Middle Aged | Male | Cause of Death | Incidence | Outcome and Process Assessment (Health Care) | Denmark - epidemiology | Female | Registries | Aged | Causality | Stents - adverse effects | Drug Delivery Systems - adverse effects | Heart diseases | Thrombosis | Stent (Surgery) | Blood clot | Mortality | Drug therapy | Cardiology | Epidemiology | Heart attacks | Hospitals | Stents | Coronary vessels
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 6, pp. 1042 - 1048
Background In ST-elevation myocardial infarction (STEMI), distal embolization of thrombus material often precludes restoration of normal coronary artery flow....
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | NO-REFLOW | PROTECTION | EMBOLIZATION | THROMBECTOMY | FOLLOW-UP | REPERFUSION | SEGMENT RESOLUTION | X-SIZER | Myocardial Infarction - mortality | Prospective Studies | Double-Blind Method | Follow-Up Studies | Angioplasty, Balloon, Coronary - methods | Humans | Treatment Outcome | Myocardial Infarction - diagnostic imaging | Sweden - epidemiology | Coronary Angiography | Myocardial Infarction - therapy | Thrombectomy - methods | Electrocardiography | Cause of Death - trends | Registries | Suction - methods | Angiography | Angioplasty | Thrombosis | Heart attack | Blood clot | Heart failure | Heart attacks | Medical imaging | Medical technology | Heart surgery | Mortality | Hospitalization | Data bases | Blood clots | Studies | Hypotheses | Coronary vessels | Veins & arteries | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | NO-REFLOW | PROTECTION | EMBOLIZATION | THROMBECTOMY | FOLLOW-UP | REPERFUSION | SEGMENT RESOLUTION | X-SIZER | Myocardial Infarction - mortality | Prospective Studies | Double-Blind Method | Follow-Up Studies | Angioplasty, Balloon, Coronary - methods | Humans | Treatment Outcome | Myocardial Infarction - diagnostic imaging | Sweden - epidemiology | Coronary Angiography | Myocardial Infarction - therapy | Thrombectomy - methods | Electrocardiography | Cause of Death - trends | Registries | Suction - methods | Angiography | Angioplasty | Thrombosis | Heart attack | Blood clot | Heart failure | Heart attacks | Medical imaging | Medical technology | Heart surgery | Mortality | Hospitalization | Data bases | Blood clots | Studies | Hypotheses | Coronary vessels | Veins & arteries | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 6, pp. 616 - 624
Abstract Background First-generation drug-eluting coronary stents (DES) were introduced in 2003 to 2004, and their use resulted in a considerable reduction in...
Cardiovascular | Internal Medicine | coronary disease | stent thrombosis | survival | angioplasty | DRUG | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EFFICACY | THROMBOSIS | SAFETY | BARE-METAL STENTS | FOLLOW-UP | MECHANISMS | IMPLANTATION | Coronary Artery Disease - surgery | Drug-Eluting Stents | Immunosuppressive Agents | Follow-Up Studies | Sirolimus | Humans | Middle Aged | Male | Treatment Outcome | Coronary Restenosis - epidemiology | Time Factors | Paclitaxel | Female | Aged | Graft Occlusion, Vascular - epidemiology | Rapamycin | Stent (Surgery) | Coronary heart disease | Patient outcomes | Heart attacks | Emigration | Values | Cardiovascular disease | Angina pectoris | Thrombosis | Patients | Clinical outcomes | Studies | Confidence intervals | Coronary vessels | Electrocardiography | Acute coronary syndromes | Stents
Cardiovascular | Internal Medicine | coronary disease | stent thrombosis | survival | angioplasty | DRUG | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EFFICACY | THROMBOSIS | SAFETY | BARE-METAL STENTS | FOLLOW-UP | MECHANISMS | IMPLANTATION | Coronary Artery Disease - surgery | Drug-Eluting Stents | Immunosuppressive Agents | Follow-Up Studies | Sirolimus | Humans | Middle Aged | Male | Treatment Outcome | Coronary Restenosis - epidemiology | Time Factors | Paclitaxel | Female | Aged | Graft Occlusion, Vascular - epidemiology | Rapamycin | Stent (Surgery) | Coronary heart disease | Patient outcomes | Heart attacks | Emigration | Values | Cardiovascular disease | Angina pectoris | Thrombosis | Patients | Clinical outcomes | Studies | Confidence intervals | Coronary vessels | Electrocardiography | Acute coronary syndromes | Stents
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2012, Volume 110, Issue 11, pp. 1585 - 1591
Diabetes is associated with increased risk of major adverse cardiac events (MACEs) after percutaneous coronary intervention. The purpose of this substudy of...
Cardiovascular | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAVASCULAR ULTRASOUND TRIAL | CLINICAL-TRIAL | IMPLANTATION | DEATH | HYPERPLASIA | CORONARY-ARTERY-DISEASE | Coronary Artery Disease - surgery | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Survival Rate - trends | Follow-Up Studies | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Male | Treatment Outcome | Coronary Artery Disease - mortality | Sirolimus - pharmacology | Coronary Artery Disease - complications | Denmark - epidemiology | Female | Retrospective Studies | Diabetes Mellitus - mortality | Everolimus | Immunosuppressive Agents - pharmacology | Diabetics | Care and treatment | Patient outcomes | Diabetes | Angiogenesis inhibitors | Comparative analysis | Cardiology | Stent (Surgery) | Cardiovascular disease | Heart attacks | Stents | Coronary vessels
Cardiovascular | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAVASCULAR ULTRASOUND TRIAL | CLINICAL-TRIAL | IMPLANTATION | DEATH | HYPERPLASIA | CORONARY-ARTERY-DISEASE | Coronary Artery Disease - surgery | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Survival Rate - trends | Follow-Up Studies | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Male | Treatment Outcome | Coronary Artery Disease - mortality | Sirolimus - pharmacology | Coronary Artery Disease - complications | Denmark - epidemiology | Female | Retrospective Studies | Diabetes Mellitus - mortality | Everolimus | Immunosuppressive Agents - pharmacology | Diabetics | Care and treatment | Patient outcomes | Diabetes | Angiogenesis inhibitors | Comparative analysis | Cardiology | Stent (Surgery) | Cardiovascular disease | Heart attacks | Stents | Coronary vessels
Journal Article